Title:
MOLECULES THAT BIND TO CD276 POLYPEPTIDES
Document Type and Number:
WIPO Patent Application WO/2023/150092
Kind Code:
A3
Abstract:
This document provides methods and materials involved in binding a binder (e.g., an antibody, antigen binding fragment, antibody domain, CAR, cell engager, and/or ADC) to a CD276 polypeptide. For example, binders (e.g., antibodies, antigen binding fragments, antibody domains, CARs, cell engagers, and/or ADCs) that bind to a CD276 polypeptide and methods and materials for using one or more such binding molecules to treat a mammal (e.g., a human) having cancer are provided.
Inventors:
DIMITROV DIMITER STANCHEV (US)
LIU XIANGLEI (US)
LI WEI (US)
MELLORS JOHN W (US)
BAEK DUSAN (US)
SUN ZEHUA (US)
LIU XIANGLEI (US)
LI WEI (US)
MELLORS JOHN W (US)
BAEK DUSAN (US)
SUN ZEHUA (US)
Application Number:
PCT/US2023/011929
Publication Date:
November 30, 2023
Filing Date:
January 31, 2023
Export Citation:
Assignee:
UNIV OF PITTSBURGH – OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US)
International Classes:
C07K16/28; A61K39/395; A61P35/00
Domestic Patent References:
| WO2017220988A1 | 2017-12-28 | |||
| WO2021247608A1 | 2021-12-09 |
Foreign References:
| US20200255534A1 | 2020-08-13 |
Attorney, Agent or Firm:
FINN III, J. Patrick et al. (US)
Download PDF:
Previous Patent: CONDENSATION RESISTANT KETONE-BASED INKJET INKS
Next Patent: IBUDILAST FOR USE IN THE TREATMENT OF POST-COVID CONDITIONS
Next Patent: IBUDILAST FOR USE IN THE TREATMENT OF POST-COVID CONDITIONS